First Trust Advisors LP Dr Reddys Laboratories LTD Transaction History

First Trust Advisors LP

$127 Billion
Q3 2025

A detailed history of First Trust Advisors LP transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, First Trust Advisors LP holds 52,389 shares of RDY stock, worth $730,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,389

Previous 65,652 20.2%

Holding current value

$730,302

Previous $986,000 25.76%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$13.33 - $15.08 $176,795 - $200,006	-13,263 Reduced 20.2%	52,389 $732,000
Q2 2025 Aug 13, 2025	BUY	$12.36 - $16.17 $153,140 - $200,346	12,390 Added 23.26%	65,652 $986,000
Q1 2025 May 14, 2025	SELL	$12.53 - $15.81 $127,392 - $160,740	-10,167 Reduced 16.03%	53,262 $702,000
Q4 2024 Feb 13, 2025	BUY	$13.99 - $79.75 $887,371 - $5.06 Million	63,429 New	63,429 $1 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $58,834 - $69,610	1,103 Added 25.84%	5,372 $339,000

Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $2.89 Million - $3.18 Million	-55,897 Reduced 92.9%	4,269 $243,000
Q4 2022 Feb 09, 2023	SELL	$51.15 - $57.45 $2.24 Million - $2.51 Million	-43,712 Reduced 42.08%	60,166 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $457,882 - $525,968	9,176 Added 9.69%	103,878 $5.44 Million
Q2 2022 Aug 12, 2022	BUY	$49.62 - $58.13 $2.57 Million - $3.02 Million	51,890 Added 121.2%	94,702 $5.25 Million
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $60,820 - $82,215	-1,260 Reduced 2.86%	42,812 $2.39 Million
Q4 2021 Feb 08, 2022	SELL	$59.5 - $67.25 $4.08 Million - $4.61 Million	-68,495 Reduced 60.85%	44,072 $2.88 Million
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $2.36 Million - $2.95 Million	-39,192 Reduced 25.83%	112,567 $7.33 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $2.27 Million - $2.71 Million	-36,462 Reduced 19.37%	151,759 $11.2 Million
Q1 2021 May 14, 2021	BUY	$57.98 - $73.08 $1.14 Million - $1.44 Million	19,712 Added 11.7%	188,221 $11.6 Million
Q4 2020 Feb 02, 2021	BUY	$62.61 - $71.29 $2.86 Million - $3.26 Million	45,724 Added 37.24%	168,509 $12 Million
Q3 2020 Nov 05, 2020	SELL	$51.39 - $72.41 $277,249 - $390,651	-5,395 Reduced 4.21%	122,785 $8.54 Million
Q2 2020 Jul 22, 2020	BUY	$39.55 - $54.65 $209,298 - $289,207	5,292 Added 4.31%	128,180 $6.8 Million
Q1 2020 May 06, 2020	BUY	$34.75 - $45.85 $407,131 - $537,178	11,716 Added 10.54%	122,888 $4.96 Million
Q4 2019 Feb 03, 2020	SELL	$36.66 - $41.78 $1.67 Million - $1.91 Million	-45,609 Reduced 29.09%	111,172 $4.51 Million
Q3 2019 Nov 04, 2019	SELL	$34.82 - $39.26 $412,233 - $464,799	-11,839 Reduced 7.02%	156,781 $5.94 Million
Q2 2019 Jul 30, 2019	BUY	$36.05 - $42.76 $1.35 Million - $1.6 Million	37,403 Added 28.5%	168,620 $6.32 Million
Q1 2019 May 09, 2019	SELL	$35.77 - $40.57 $386,387 - $438,237	-10,802 Reduced 7.61%	131,217 $5.31 Million
Q4 2018 Feb 07, 2019	SELL	$31.89 - $38.44 $6.82 Million - $8.22 Million	-213,829 Reduced 60.09%	142,019 $5.35 Million
Q3 2018 Oct 25, 2018	SELL	$29.25 - $36.73 $1.91 Million - $2.4 Million	-65,365 Reduced 15.52%	355,848 $12.3 Million
Q2 2018 Aug 02, 2018	BUY	$28.49 - $35.06 $1.69 Million - $2.08 Million	59,234 Added 16.36%	421,213 $13.6 Million
Q1 2018 Apr 23, 2018	BUY	$31.93 - $39.54 $1.81 Million - $2.24 Million	56,615 Added 18.54%	361,979 $11.8 Million
Q4 2017 Feb 08, 2018	SELL	$34.15 - $37.62 $3.63 Million - $4 Million	-106,426 Reduced 25.84%	305,364 $11.5 Million
Q3 2017 Oct 24, 2017	BUY	$30.11 - $37.72 $12.4 Million - $15.5 Million	411,790	411,790 $14.7 Million

Others Institutions Holding RDY

# of Institutions

250

Shares Held

94.4M

Call Options Held

Put Options Held

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Dr Reddys Laboratories LTD Transaction History